New Zealand markets closed
  • NZX 50

    11,814.34
    -38.59 (-0.33%)
     
  • NZD/USD

    0.6283
    0.0000 (-0.00%)
     
  • NZD/EUR

    0.6172
    +0.0005 (+0.08%)
     
  • ALL ORDS

    7,359.30
    -21.80 (-0.30%)
     
  • ASX 200

    7,114.60
    -13.10 (-0.18%)
     
  • OIL

    88.33
    +0.22 (+0.25%)
     
  • GOLD

    1,778.30
    +1.60 (+0.09%)
     
  • NASDAQ

    13,470.86
    -164.35 (-1.21%)
     
  • FTSE

    7,515.75
    -20.31 (-0.27%)
     
  • Dow Jones

    33,980.32
    -171.69 (-0.50%)
     
  • DAX

    13,626.71
    -283.41 (-2.04%)
     
  • Hang Seng

    19,812.36
    -110.09 (-0.55%)
     
  • NIKKEI 225

    28,976.48
    -246.29 (-0.84%)
     
  • NZD/JPY

    84.7730
    -0.0320 (-0.04%)
     

Extracellular Vesicles 2022: Two Day Conference - Biology, Disease & Medicine (Washington, United States - September 13-14, 2022)

·2-min read
Company Logo
Company Logo

Dublin, July 06, 2022 (GLOBE NEWSWIRE) -- The "Extracellular Vesicles 2022: Biology, Disease & Medicine" conference has been added to ResearchAndMarkets.com's offering.

The host is pleased to welcome you all to the Extracellular Vesicles 2022: Biology, Disease & Medicine Conference to be held on-site in-person live in beautiful downtown Seattle.

This conference is held co-located and concurrently with the SelectBIO 3D-Models for Drug Testing: Organoids and Tissue Chips 2022 Conference. All attendees receive full access to both tracks and the networking opportunities during the Food & Beverage events.

This Extracellular Vesicles 2022 Conference focuses on the emerging technologies and tools that are driving the field forward. Technologies such as Flow Cytometry and Single EV Analysis will be highlighted in this conference track. Another theme will be the use of Microfluidics for the Study of EVs in Particular and Circulating Biomarkers in General.

The EV Track brings together technologies and their utilization to study EVs in research, biomarker cargo studies as well as therapeutics development.

Agenda:

  • Downstream Analysis of Biomarker Cargo Contained in Extracellular Vesicles (EVs)/Exosomes

  • Harvesting Biological Value from EVs: Biomarker Potential, Therapeutic Potential

  • Diagnostics Development

  • EVs in Cancer

  • EVs in Cardiovascular Disease

  • EVs in Wound Healing

  • Extracellular Vesicles and Stem Cells - An Emerging Area of Investigation for Regenerative Medicine

  • Therapeutics Development + Drug Delivery via Engineered EVs

  • Single Cell and Vesicle Studies by Flow Cytometry and Microfluidics

  • Tools & Technologies for Isolation of Extracellular Vesicles (EVs)/Exosomes

Conference Chairs

Michael Graner
Professor, University of Colorado Anschutz School of Medicine

Lucia R. Languino
Professor of Cancer Biology, Thomas Jefferson University

Keynote Speakers

Daniel Chiu
A. Bruce Montgomery Professor of Chemistry, University of Washington

Jennifer Jones
NIH Stadtman Investigator, Head of Transnational Nanobiology, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute

Lynn Pulliam
Professor of Laboratory Medicine and Medicine, University of California San Francisco

Danilo Tagle
Director, Office of Special Initiatives, National Center for Advancing Translational Sciences at the NIH (NCATS)

Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands

Kendall Van Keuren-Jensen
Professor and Deputy Director, Translational Genomics Research Institute

For more information about this conference visit https://www.researchandmarkets.com/r/yag8h2


CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting